PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 2, 2017European Journal of Heart Failure102 citationsOpen Access

Pulmonary Hypertension Due to Left Heart Disease: Analysis of Survival According to the Haemodynamic Classification of the 2015 ESC/ERS Guidelines and Insights for Future Changes

View Full Paper
MPMassimiliano PalazziniGeneral CardiologyFDFabio DardiHeart Failure & TransplantAMAlessandra ManesVascular Medicine

Key Points

  • This study aims to evaluate the prognostic value of isolated post-capillary and combined post- and pre-capillary pulmonary hypertension resulting from left heart disease.
  • Included data from 276 consecutive incident patients with pulmonary hypertension due to left heart disease.
  • Patients were classified based on diastolic pressure gradient and pulmonary vascular resistance according to 2015 ESC/ERS guidelines.
  • Survival was estimated using the Kaplan-Meier method and compared between patient groups using the log-rank test.
  • Patients with isolated post-capillary pulmonary hypertension (Ipc-PH) had better survival compared to combined post- and pre-capillary pulmonary hypertension (Cpc-PH) (P = 0.026).
  • No survival difference was found between patients with Cpc-PH and an intermediate group (P = 0.891).
  • Patients with normal pulmonary vascular resistance had a better survival compared to those with elevated resistance (P = 0.012).

Abstract

AIMS: Pulmonary hypertension (PH) is a relevant complication of left heart disease (LHD). The 2015 ESC/ERS PH guidelines report two different haemodynamic subsets of PH due to LHD (PH-LHD) based on levels of pulmonary vascular resistance (PVR) and diastolic pressure gradient (DPG): isolated post-capillary PH (Ipc-PH) and combined post- and pre-capillary PH (Cpc-PH). The objective of this study is to evaluate the prognostic value of Ipc-PH and Cpc-PH. METHODS AND RESULTS: Data from 276 consecutive incident patients with PH-LHD were included. According to the guidelines, Ipc-PH is defined by DPG 3 WU. Using this definition, we identified three patient groups: Ipc-PH with both normal PVR and DPG (108 patients); Cpc-PH with both increased PVR and DPG (66 patients); and an intermediate group with either increased PVR or DPG (102 patients). Survival was estimated using the Kaplan-Meier method and compared between groups using the log-rank test. Patients with Ipc-PH had better survival compared with the group of patients with Cpc-PH (P = 0.026) and the intermediate group (P = 0.025). No survival difference was detected between patients with Cpc-PH and the intermediate group (P = 0.891). Patients with normal PVR had a better survival compared with those with elevated PVR (P = 0.012); while no difference was observed according to the level of DPG (P = 0.253). CONCLUSION: Patients with Ipc-PH have a better prognosis compared with patients with Cpc-PH and with patients with isolated increase of PVR or DPG. Pulmonary vascular resistance has a better predictive value than DPG in patients with PH-LHD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Palazzini et al. (2017) studied this question.

synapsesocial.com/papers/6a064cab0924dc877016d8cdhttps://doi.org/10.1002/ejhf.860
Ask AI
Helpful
Bookmark
Share
View Full Paper